CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONTINGENTLY REDEEMABLE NONCONTROLLING INTEREST AND EQUITY - USD ($) $ in Millions		Total		Series C Preferred Stock	Sempra shareholders' equity	Sempra shareholders' equity Series C Preferred Stock	Preferred stock	Common stock	Retained earnings	Retained earnings Series C Preferred Stock	Accumulated other comprehensive income (loss)	NCI
Beginning Balance at Dec. 31, 2024		$ 37,788			$ 31,222		$ 889	$ 13,520	$ 16,979		$ (166)	$ 6,566
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		919			917				917			2
Other comprehensive income (loss)		(34)			(29)						(29)	(5)
Share-based compensation expense		(2)			(2)			(2)
Dividends declared:
Preferred dividends				$ (11)		$ (11)				$ (11)
Common stock dividends		(420)			(420)				(420)
Issuances of common stock		23			23			23
Repurchases of common stock		(57)			(57)			(57)
CRNCI and NCI activities:
Contributions		34										34
Distributions to NCI		(38)										(38)
Ending balance at Mar. 31, 2025		38,202			31,643		889	13,484	17,465		(195)	6,559
Beginning balance at Dec. 31, 2025	[1]	3,206
CRNCI
Net income		6
Allocation of interests		42
Ending balance at Mar. 31, 2026		3,254
Beginning Balance at Dec. 31, 2025		38,793	[1]		31,594		0	14,699	17,092		(197)	7,199
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,144			1,037				1,037			107
Net income		1,150
Other comprehensive income (loss)		7			6						6	1
Share-based compensation expense		25			25			25
Dividends declared:
Common stock dividends		(430)			(430)				(430)
Issuances of common stock		21			21			21
Repurchases of common stock		(20)			(20)			(20)
CRNCI and NCI activities:
Allocation of interests		(42)			6			6				(48)
Contributions		41										41
Distributions to NCI		(65)										(65)
Ending balance at Mar. 31, 2026		$ 39,474			$ 32,239		$ 0	$ 14,731	$ 17,699		$ (191)	$ 7,235

[1] Derived from audited financial statements.